0002038193-24-000002.txt : 20240924 0002038193-24-000002.hdr.sgml : 20240924 20240924115714 ACCESSION NUMBER: 0002038193-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240924 DATE AS OF CHANGE: 20240924 EFFECTIVENESS DATE: 20240924 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synapticure, Inc. CENTRAL INDEX KEY: 0002038193 ORGANIZATION NAME: IRS NUMBER: 842468810 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-524793 FILM NUMBER: 241318471 BUSINESS ADDRESS: STREET 1: 2045 W. GRAND AVE STREET 2: SUITE B CITY: CHICAGO STATE: IL ZIP: 60612 BUSINESS PHONE: 202-468-6893 MAIL ADDRESS: STREET 1: 2045 W. GRAND AVE STREET 2: SUITE B CITY: CHICAGO STATE: IL ZIP: 60612 D 1 primary_doc.xml X0708 D LIVE 0002038193 Synapticure, Inc. 2045 W. Grand Ave Suite B CHICAGO IL ILLINOIS 60612 202-468-6893 DELAWARE None None Corporation true 2019 Sandra Abrevaya 2045 W. Grand Ave Suite B Chicago IL ILLINOIS 60612 Executive Officer Director Brian Wallach 2045 W. Grand Ave Suite B Chicago IL ILLINOIS 60612 Director Jason Langheier 2045 W. Grand Ave Suite B Chicago IL ILLINOIS 60612 Director Adam Seabrook 2045 W. Grand Ave Suite B Chicago IL ILLINOIS 60612 Director Joe Leinbach 2045 W. Grand Ave Suite B Chicago IL ILLINOIS 60612 Executive Officer Peter Wallach 2045 W. Grand Ave Suite B Chicago IL ILLINOIS 60612 Executive Officer Eric Anderson 2045 W. Grand Ave Suite B Chicago IL ILLINOIS 60612 Executive Officer Other Health Care Decline to Disclose 06b false 2024-09-09 false true false 0 40145500 40145500 0 Includes shares of preferred stock issued pursuant to the cancellation of SAFE indebtedness in the amount of $16,645,500. false 51 0 0 0 false Synapticure, Inc. /s/ Sandra Abrevaya Sandra Abrevaya Chief Executive Officer 2024-09-24